JP2015500464A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500464A5
JP2015500464A5 JP2014543985A JP2014543985A JP2015500464A5 JP 2015500464 A5 JP2015500464 A5 JP 2015500464A5 JP 2014543985 A JP2014543985 A JP 2014543985A JP 2014543985 A JP2014543985 A JP 2014543985A JP 2015500464 A5 JP2015500464 A5 JP 2015500464A5
Authority
JP
Japan
Prior art keywords
selectin
substrate
stroke
vcam
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014543985A
Other languages
English (en)
Japanese (ja)
Other versions
JP6199880B2 (ja
JP2015500464A (ja
Filing date
Publication date
Priority claimed from GB1120781.8A external-priority patent/GB2497138A/en
Application filed filed Critical
Publication of JP2015500464A publication Critical patent/JP2015500464A/ja
Publication of JP2015500464A5 publication Critical patent/JP2015500464A5/ja
Application granted granted Critical
Publication of JP6199880B2 publication Critical patent/JP6199880B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014543985A 2011-12-02 2012-12-03 脳卒中の診断を補助するためのバイオマーカーに基づく方法およびバイオチップ Active JP6199880B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1120781.8 2011-12-02
GB1120781.8A GB2497138A (en) 2011-12-02 2011-12-02 Biomarkers for stroke and stroke subtype diagnosis.
PCT/GB2012/052993 WO2013079981A2 (en) 2011-12-02 2012-12-03 Biomarker-based methods and biochips for aiding the diagnosis of stroke

Publications (3)

Publication Number Publication Date
JP2015500464A JP2015500464A (ja) 2015-01-05
JP2015500464A5 true JP2015500464A5 (enExample) 2016-01-28
JP6199880B2 JP6199880B2 (ja) 2017-09-20

Family

ID=45509085

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014543985A Active JP6199880B2 (ja) 2011-12-02 2012-12-03 脳卒中の診断を補助するためのバイオマーカーに基づく方法およびバイオチップ

Country Status (8)

Country Link
US (2) US20150126385A1 (enExample)
EP (1) EP2786155B1 (enExample)
JP (1) JP6199880B2 (enExample)
CN (1) CN104272112B (enExample)
AU (2) AU2012343537B2 (enExample)
CA (1) CA2857589C (enExample)
GB (1) GB2497138A (enExample)
WO (1) WO2013079981A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201309928D0 (en) 2013-06-04 2013-07-17 Randox Lab Ltd Method
JP6312302B2 (ja) * 2014-01-06 2018-04-18 公益財団法人ヒューマンサイエンス振興財団 脳梗塞の診断マーカー
KR102356418B1 (ko) 2017-06-13 2022-02-08 에프. 호프만-라 로슈 아게 심방 세동 (af) 의 평가를 위한 지방산 결합 단백질 3
GB2563415A (en) * 2017-06-14 2018-12-19 Randox Laboratories Ltd Combinations for use in stroke diagnosis
GB2563414A (en) * 2017-06-14 2018-12-19 Randox Laboratories Ltd Improvements in stroke diagnostics
JP6499342B2 (ja) * 2018-03-19 2019-04-10 隆樹 日和佐 脳梗塞の診断マーカー
KR102299968B1 (ko) * 2019-11-19 2021-09-09 경북대학교 산학협력단 혈액성분 분리용 다중필터 및 그를 이용한 질병 진단키트

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5879010A (en) 1997-07-22 1999-03-09 Green Tweed Of Delaware, Inc. Seal assembly with mechanically joined anti-extrusion rings
GB9929140D0 (en) 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke
AU2001280996A1 (en) 2000-08-04 2002-02-18 Cis Biotech, Inc. Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
WO2003016910A1 (en) * 2001-08-20 2003-02-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
CA2358007C (en) * 2001-10-02 2008-02-19 Royce Technologies Llc, A Nevada Corporation Ceramic biomolecule imaging chip
EP2341350B1 (en) * 2003-09-20 2017-11-08 Electrophoretics Limited Diagnostic method for brain damage-related disorders based on detection of dj-1
US7634360B2 (en) * 2003-09-23 2009-12-15 Prediction Sciences, LL Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
US7392140B2 (en) * 2003-09-23 2008-06-24 Prediction Sciences, Llc Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
US20050181386A1 (en) * 2003-09-23 2005-08-18 Cornelius Diamond Diagnostic markers of cardiovascular illness and methods of use thereof
US20060099608A1 (en) * 2004-03-29 2006-05-11 Medstar Research Institute Methods of diagnosing cardiovascular disease
WO2007124439A2 (en) * 2006-04-21 2007-11-01 Rules-Based Medicine, Inc. Diagnosis of stroke using metalloproteinase or transaminase
CA2688433A1 (en) * 2007-06-06 2008-12-11 Domantis Limited Methods for selecting protease resistant polypeptides
WO2010012834A1 (en) 2008-08-01 2010-02-04 Bio-Rad Pasteur Method for the in vitro diagnosis of stroke
CN102257386B (zh) * 2008-10-24 2014-12-31 B.R.A.H.M.S有限公司 通过测定标志肽的水平在已患过中风或短暂性缺血性发作的患者中进行预后和风险评估
EP2206726A1 (en) * 2009-01-08 2010-07-14 Universite Joseph Fourier Non-invasive tools for detecting vulnerable atherosclerotic plaques
WO2010086697A1 (en) 2009-01-30 2010-08-05 Bio-Rad Pasteur Method for the in vitro diagnosis of stroke

Similar Documents

Publication Publication Date Title
JP2015500464A5 (enExample)
Kumar et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure
Standage et al. Biomarkers for pediatric sepsis and septic shock
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
BRPI0607753A2 (pt) método para prever um efeito clìnico em resposta a um tratamento de uma leucemia; método para prever um efeito clìnico de uma leucemia; método para selecionar um tratamento para um paciente com leucemia; método para o diagnóstico ou monitoramento de ocorrência, desenvolvimento, progressão ou tratamento de uma leucemia; arranjo para uso num método para prever um efeito clìnico para um paciente aml; arranjo para uso num método de diagnóstico de aml; meio legìvel por computador; kit para o prognóstico de aml
WO2010053587A3 (en) Methods of monitoring conditions by sequence analysis
HK1205764A1 (en) Tuberculosis biomarkers and uses thereof
WO2013062515A3 (en) Lung cancer biomarkers and uses thereof
JP2016118568A5 (enExample)
RU2016137685A (ru) Способ диагностики туберкулеза
RU2013118341A (ru) Получение сыворотки
WO2013040099A3 (en) Sepsis prognosis biomarkers
JP2013503617A5 (enExample)
Engstrom-Melnyk et al. Clinical applications of quantitative real-time PCR in virology
Zwaenepoel et al. The prognostic value of cardiac biomarkers and echocardiography in critical COVID-19
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
JP2017533714A5 (enExample)
Nickel et al. Risk stratification using D-dimers in patients presenting to the emergency department with nonspecific complaints
Kollias et al. Is white-coat hypertension a harbinger of increased risk?
WO2010148323A3 (en) Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus-related virus
Noh et al. Clinical performance of the Sofia™ Influenza A+ B FIA in adult patients with influenza-like illness
Loni et al. The evaluation of C-reactive protein as a screening tool for neonatal sepsis
Hall et al. Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience.
Salvagno et al. The role of acute phase proteins for predicting SARS-CoV-2 positivity upon emergency department admission